Sellas Life Sciences Group Inc
Change company Symbol lookup
Select an option...
SLS Sellas Life Sciences Group Inc
BFST Business First Bancshares Inc
SAN Banco Santander SA
AXP American Express Co
GRPN Groupon Inc
JPM JPMorgan Chase & Co
BIDU Baidu Inc
PJET Priority Aviation Inc
CY Cypress Semiconductor Corp
UOCT Innovator S&P 500 Ultra Buffer ETF - October
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

SELLAS Life Sciences Group, Inc., formerly Galena Biopharma, Inc., is a biopharmaceutical company. The Company focuses on developing and commercializing targeted oncology therapeutics that address unmet medical needs. The Company's development portfolio ranges from mid- to late-stage clinical assets, including cancer immunotherapy program led by NeuVax (nelipepimut-S), GALE-301 and GALE-302. The Company's NeuVax is in Phase III breast cancer clinical trial with several concurrent Phase II trials ongoing both as a single agent and in combination with other therapies. GALE-301 is in a Phase IIa clinical trial in ovarian and endometrial cancers and in a Phase Ib clinical trial given sequentially with GALE-302. The Company's therapies utilize an immunodominant peptide combined with the immune adjuvant, recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF, Leukine), and work by harnessing the patient's own immune system.

Closing Price
$0.9476
Day's Change
-0.0124 (-1.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.96
Day's Low
0.93
Volume
(Light)
Volume:
313,503

10-day average volume:
421,861
313,503
  • Prev Close
    0.96
  • Today's Open
    0.957
  • Day's Range
    0.93-0.96
  • Avg Vol (10-day)
    421.9K
  • Last (time)
    4:00p ET 04/22/19
  • Last (size)
    824
  • 52-Wk Range
    0.8001 - 6.97
    LowHigh
  • (06/01/18 - 08/20/18)
    18.44%
  • 109.5%
  • Market Cap
    22.0M
  • Shares Outstanding
    23.2M
  • -4.08
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.7
  • 24.00
  • (% of float 03/29/19)
    12.45

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.